By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Deciphera Pharmaceuticals 

1505 Wakarusa Drive

Lawrence  Kansas  66047  U.S.A.
Phone: 785-838-3767 Fax: 785-838-3747


SEARCH JOBS


Industry
Pharmaceutical






Company News
Deciphera Pharmaceuticals Presents Data On Altiratinib (DCC-2701), An Advanced Multi-Targeted Kinase Inhibitor, At 26th EORTC-NCI-AACR Symposium On Molecular Targets And Cancer Therapeutics 11/20/2014 11:21:05 AM
Deciphera Pharmaceuticals Presents Data On Altiratinib (DCC-22701) That Demonstrated Inhibition Of Tumor Growth And Invasion In Bevacizumab Resistant Glioblastoma 11/17/2014 11:31:02 AM
Deciphera Pharmaceuticals Appoints Oliver Rosen M.D. As Chief Medical Officer 6/30/2014 9:51:30 AM
Deciphera Pharmaceuticals Announces Initiation Of Phase 1 Cancer Trial For Altiratinib (DCC-2701) MET/TIE2/VEGFR/TRK Kinase Inhibitor For Solid Tumors 5/30/2014 9:36:50 AM
Deciphera Pharmaceuticals Appoints Michael D. Taylor, Ph.D., As President And Chief Executive Officer 4/7/2014 3:01:53 PM
Deciphera Pharmaceuticals Announces Initiation Of Phase 1 Cancer Trial For LY3009120 4/7/2014 9:43:46 AM
Eli Lilly and Company (LLY) (JOBS) and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement 10/3/2008 6:20:46 AM
Deciphera Pharmaceuticals Raises $15M Series B10/19/2005 5:09:34 PM
//-->